LUCILLE VENTURANZA: Open Payments
NPI 1033269881 · TOWANDA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,660 in 91 payments from 10 companies in 2025. Trend: 2023 $459 · 2024 $1,594 · 2025 $2,660
Food & beverage: $2,660
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 17 | $538 |
| Vanda Pharmaceuticals Inc. | 13 | $497 |
| Alkermes, Inc. | 15 | $429 |
| Otsuka America Pharmaceutical, Inc. | 13 | $398 |
| Neurocrine BioSciences, Inc. | 7 | $180 |
| Janssen Pharmaceuticals, Inc | 5 | $177 |
| Axsome Therapeutics, Inc. | 6 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $136 |
| Lundbeck LLC | 6 | $112 |
| Teva Pharmaceuticals USA, Inc. | 3 | $47 |
Products named: COBENFY, FANAPT, ARISTADA, REXULTI, INGREZZA, ABILIFY MAINTENA, INVEGA SUSTENNA, Auvelity.
Industry payments across PA — which companies pay providers there.
